Evidence map›Paper›PMID 22231568›Full record

ArticleArthritis and rheumatism2012

Evaluation of TRAF6 in a large multiancestral lupus cohort.

Bahram Namjou, Chan-Bum Choi, Isaac T W Harley, Marta E Alarcón-Riquelme, BIOLUPUS Network, Jennifer A Kelly, Stuart B Glenn, Joshua O Ojwang, Adam Adler, Kwangwoo Kim and 39 more

Open access · bronzeAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Deletions inCell reports. Medicine · 2021
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Regulation of Treg Functions by the Ubiquitin Pathway.Advances in experimental medicine and biology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Haematological manifestations of lupus.Lupus science & medicine · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors at 20 institutions in 7 countries.

Bahram NamjouCincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Chan-Bum Choi
Isaac T W Harley
Marta E Alarcón-Riquelme
BIOLUPUS Network
Jennifer A Kelly
Stuart B Glenn
Joshua O Ojwang
Adam Adler
Kwangwoo Kim
Caroline J Gallant
Susan A Boackle
Lindsey A Criswell
Robert P Kimberly
Elizabeth E Brown
Jeffrey Edberg
Graciela S Alarcón
Anne M Stevens
Chaim O Jacob
Gary S Gilkeson
Diane L Kamen
Betty P Tsao
Juan-Manuel Anaya
Eun-Mi Kim
So-Yeon Park
Yoon-Kyoung Sung
Joel M Guthridge
Joan T Merrill
Michelle Petri
Rosalind Ramsey-Goldman
Luis M Vilá
Timothy B Niewold
Javier Martin
Bernardo A Pons-Estel
Genoma en Lupus Network
Timothy J Vyse
Barry I Freedman
Kathy L Moser
Patrick M Gaffney
Adrienne H Williams
Mary E Comeau
John D Reveille
Changwon Kang
Judith A James
R Hal Scofield
Carl D Langefeld
Kenneth M Kaufman
John B Harley
Sang-Cheol Bae
Oklahoma Medical Research Foundation · USHanyang University · KRUniversity of Alabama at Birmingham · USWake Forest University · USCincinnati Children's Hospital Medical Center · USKorea Advanced Institute of Science and Technology · KRMedical University of South Carolina · USUniversity of Oklahoma · USUppsala University · SEJohns Hopkins University · USKing's College London · GBNorthwestern University · USThe University of Texas Health Science Center at Houston · USUniversidad del Rosario · COUniversity of California, Los Angeles · USUniversity of California, San Francisco · USUniversity of Chicago · USUniversity of Cincinnati · USUniversity of Colorado Boulder · USUniversity of Puerto Rico System · PR

Funding

Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI LIU, CAMBRIAN YANGSHAO · 1990 to 2025
$29.8M
U OF TEXAS HLTH SCI CTR HOUSTON CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCESUL1RR024148 · NCRR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2006 to 2010
$27.9M
ZD1839 FOR MALIGNANT ASTROCYTOMA OR GLIOBLASTOMA AND MENINGIOMAM01RR000079 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KESSLER, DAVID A · 1985 to 2006
$26.0M
TRANSLATIONAL RESEARCH UNIVERSITY OF CHICAGO: CLINICAL TRIALSUL1RR024999 · NCRR · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2007 to 2011
$25.3M
MULTIDISCIPLINARY CLINICAL AND TRANSLATIONAL SCIENCE (MCTS) PROGRAM (UL1)UL1RR025741 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GREENLAND, PHILIP · 2008 to 2011
$24.7M
UAB CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE (CCTS) UL1: BPCAUL1RR025777 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUAY-WOODFORD, LISA MARIE · 2008 to 2011
$22.3M
THE EFFECTS OF ERK PATHWAY INHIBITION ON DNA METHYLATION IN SLEP20RR015577 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI CENTOLA, MICHAEL B · 2000 to 2009
$21.5M
VALIDATING NOVEL GENES IMPLICATED IN LEUKOCYTE CHEMOTAXISP20RR020143 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2004 to 2011
$21.0M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
Program Project in the Genetics of SLEP01AR049084 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2002 to 2012
$12.7M
The Interplay of Sociodemographic and Genetic Factors in SLE Health DisparitiesP60AR053308 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YELIN, EDWARD H · 2006 to 2016
$11.8M
BLRD VA I01 BX003850NCATS NIH HHS UL1 TR000062NCATS NIH HHS UL1 TR000154NCI NIH HHS CA-141700-01NCI NIH HHS R01 CA141700NCRR NIH HHS 5UL1-RR-025777NCRR NIH HHS M01 RR000079NCRR NIH HHS M01-RR-00079NCRR NIH HHS P20 RR015577NCRR NIH HHS P20-RR-015577NCRR NIH HHS P20 RR020143NCRR NIH HHS P20-RR-020143NCRR NIH HHS P30 RR031152NCRR NIH HHS RR-031152NCRR NIH HHS UL1 RR024148NCRR NIH HHS UL1 RR024999NCRR NIH HHS UL1-RR-024999NCRR NIH HHS UL1 RR025005NCRR NIH HHS UL1-RR-025005NCRR NIH HHS UL1 RR025741NCRR NIH HHS UL1-RR-025741NCRR NIH HHS UL1 RR025777NCRR NIH HHS UL1 RR029882NCRR NIH HHS UL1-RR-029882NIAID NIH HHS AI-063622NIAID NIH HHS AI-071651NIAID NIH HHS K08 AI083790NIAID NIH HHS K08-AI-083790NIAID NIH HHS K24 AI078004NIAID NIH HHS L30 AI071651NIAID NIH HHS P01 AI083194NIAID NIH HHS P01-AI-083194NIAID NIH HHS R01 AI063622NIAID NIH HHS R21 AI070304NIAID NIH HHS R21-AI-070304NIAID NIH HHS R37 AI024717NIAID NIH HHS R37-AI-024717NIAID NIH HHS U19 AI082714NIAID NIH HHS U19-AI-082714NIAMS NIH HHS AR-043274NIAMS NIH HHS AR-043814NIAMS NIH HHS AR-044804NIAMS NIH HHS AR-052300NIAMS NIH HHS AR-053483NIAMS NIH HHS AR-058554NIAMS NIH HHS AR-060366NIAMS NIH HHS AR-42525NIAMS NIH HHS AR-43727NIAMS NIH HHS K24 AR002138NIAMS NIH HHS K24-AR-002138NIAMS NIH HHS N01 AR062277NIAMS NIH HHS N01-AR-062277NIAMS NIH HHS P01 AR049084NIAMS NIH HHS P01-AR-049084NIAMS NIH HHS P30 AR053483NIAMS NIH HHS P50 AR048940NIAMS NIH HHS P50-AR-048940NIAMS NIH HHS P60-2-AR-030692NIAMS NIH HHS P60 AR030692NIAMS NIH HHS P60 AR049459NIAMS NIH HHS P60-AR-049459NIAMS NIH HHS P60 AR053308NIAMS NIH HHS P60-AR-053308NIAMS NIH HHS P60 AR062755NIAMS NIH HHS R01 AR033062NIAMS NIH HHS R01 AR042460NIAMS NIH HHS R01-AR-042460NIAMS NIH HHS R01 AR042525NIAMS NIH HHS R01 AR043274NIAMS NIH HHS R01 AR043727NIAMS NIH HHS R01 AR043814NIAMS NIH HHS R01 AR044804NIAMS NIH HHS R01 AR052300NIAMS NIH HHS R01 AR057172NIAMS NIH HHS R01 AR060366NIAMS NIH HHS R01-AR-33062NIAMS NIH HHS RC1 AR058554NICHD NIH HHS HD-07463NICHD NIH HHS T32 HD007463NIDDK NIH HHS P30 DK042086NIDDK NIH HHS P30-DK-42086NIGMS NIH HHS GM-063483NIGMS NIH HHS T32 GM063483
6 · The paper itself

Abstract

objectiveSystemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with significant immune system aberrations resulting from complex heritable genetics as well as environmental factors. We undertook to study the role of TRAF6 as a candidate gene for SLE, since it plays a major role in several signaling pathways that are important for immunity and organ development.

methodsFifteen single-nucleotide polymorphisms (SNPs) across TRAF6 were evaluated in 7,490 SLE patients and 6,780 control subjects from different ancestries. Population-based case-control association analyses and meta-analyses were performed. P values, false discovery rate q values, and odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated.

resultsEvidence of associations was detected in multiple SNPs. The best overall P values were obtained for SNPs rs5030437 and rs4755453 (P = 7.85 × 10(-5) and P = 4.73 × 10(-5) , respectively) without significant heterogeneity among populations (P = 0.67 and P = 0.50, respectively, in Q statistic). In addition, SNP rs540386, which was previously reported to be associated with rheumatoid arthritis (RA), was found to be in linkage disequilibrium with these 2 SNPs (r(2) = 0.95) and demonstrated evidence of association with SLE in the same direction (meta-analysis P = 9.15 × 10(-4) , OR 0.89 [95% CI 0.83-0.95]). The presence of thrombocytopenia improved the overall results in different populations (meta-analysis P = 1.99 × 10(-6) , OR 0.57 [95% CI 0.45-0.72], for rs5030470). Finally, evidence of family-based association in 34 African American pedigrees with the presence of thrombocytopenia was detected in 1 available SNP (rs5030437) with a Z score magnitude of 2.28 (P = 0.02) under a dominant model.

conclusionOur data indicate the presence of association of TRAF6 with SLE, consistent with the previous report of association with RA. These data provide further support for the involvement of TRAF6 in the pathogenesis of autoimmunity.

Indexed as

Polymorphism, Single NucleotideAllelesCase-Control StudiesCohort StudiesFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHaplotypesHumansLupus Erythematosus, SystemicMaleTNF Receptor-Associated Factor 6TNF Receptor-Associated Factor 6

Identifiers

PMID22231568
PMCPMC3380425
OpenAlexW2072803699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.